Gemphire Therapeutics
Why Robinhood?
You can watch GEMP and buy or sell other stocks, ETFs, and their options commission-free!About GEMP
Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand.
GEMP Key Statistics
Stock Snapshot
As of today, Gemphire Therapeutics(GEMP) shares are valued at $8.18. The company's market cap stands at 42.25M, with a P/E ratio of -0.25.
On 2026-07-26, Gemphire Therapeutics(GEMP) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.03M.
Over the past 52 weeks, Gemphire Therapeutics(GEMP) stock has traded between a high of $19.03 and a low of $0.97.
Over the past 52 weeks, Gemphire Therapeutics(GEMP) stock has traded between a high of $19.03 and a low of $0.97.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.